公开(公告)号：EP4424317A1

公开(公告)日：2024-09-04

申请号：EP22886104.3

申请日：2022-10-28

申请人： Anhui Hygeiancells Biomedical Co. Ltd

发明人： QIAN, Jin ,  LI, Shiyan ,  WANG, Rong

IPC分类号： A61K35/57 ,  A61P1/00

CPC分类号： Y02A50/30 ,  A61P1/00 ,  A61K35/57

摘要： Provided is a medicine for preventing or treating enteritis and intestinal cancer. Specifically, the present invention relates to a use of amniotic fluid in the preparation of a medicine for treating or preventing enteritis in a subject, a use in the preparation of a medicine for preventing intestinal cancer in a subject, and a use in the preparation of a medicine for activating Nrf2 and inhibiting NF-κB to reduce inflammation and oxidative damage caused by damage to the intestinal mucosa barrier of a subject; the amniotic fluid comes from eggs at embryo ages of 5-12 days, eggs from birds other than chickens at the development stage corresponding to the development stage of chickens at said embryo age, embryos of rodents at a gestational age of 8-14 days, or embryos of non-human mammals other than rodents at the development stage corresponding to the development stage of rodents at a gestational age of 8-14 days.